Heart failure & cardiomyopathies
Monitoring Disease Progression in Patients With Transthyretin Amyloid Cardiomyopathy
Recommendations
As issued by the authors
Criteria with meaningful thresholds and monitoring frequency recommendations, designed to measure disease progression in ATTR-CM rather than progression of amyloid deposition
Whether disease progression indicates modification of ATTR-CM treatment remains unknown
Original publication
Monitoring Disease Progression in Patients With Transthyretin Amyloid Cardiomyopathy. JACC Heart Fail. Published 1 December 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →